Multicomponent prophylactic vaccine antigens

Multicomponent prophylactic vaccine antigens refer to a strategic combination of multiple antigenic components derived from one or more pathogens, designed to elicit a broad and robust protective immune response. These components often include recombinant proteins, toxoids, or conjugated polysaccharides that represent various serotypes or essential virulence factors of a target organism (WHO, 2021). By incorporating multiple antigens, these vaccines can overcome the high genetic diversity of pathogens like Neisseria meningitidis or Streptococcus pneumoniae, ensuring wider coverage than single-component formulations (PubMed, PMID: 24076301). The primary biological function of these antigens is to be recognized by the host's adaptive immune system, leading to the generation of high-affinity antibodies and long-lived memory B and T cells (NIH, 2022). In clinical practice, this approach is exemplified by vaccines such as Bexsero for Meningitis B or the 9-valent HPV vaccine, which provide comprehensive prophylaxis against complex infectious threats. However, the development of such multicomponent systems requires careful optimization to ensure that the individual antigens do not interfere with each other's immunogenicity or increase the risk of adverse systemic reactions (PubMed, PMID: 30245168).

Other names

Multivalent vaccine antigensPolyvalent vaccine antigensCombination vaccine antigensMixed vaccine antigensBexsero antigens

Induction of active immunity by presenting multiple pathogen-specific epitopes to the host immune system, triggering B-cell maturation, antibody production, and T-cell activation to establish long-term immunological memory (CDC, 2023; WHO, 2021).